Xtant Medical Enters Distribution Agreement with Vivex Biomedical for OsteoVive Cellular Allograft

Xtant Medical entered into a distribution relationship with Vivex Biomedical to commercialize OsteoVive™ viable cell allograft.

Vivex will process the allograft for Xtant's U.S. distribution, for use in spine and orthopaedic procedures.

Vivex Biomedical’s proprietary process preserves a cell population that includes marrow-isolated adult...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us